CHF364.00
4.21% yesterday
SIX Swiss Exchange, Nov 15, 05:31 pm CET
ISIN
CH0019396990
Symbol
YPSN
Sector

Ypsomed Target price 2024 - Analyst rating & recommendation

Ypsomed Classifications & Recommendation:

Buy
43%
Hold
43%
Sell
14%

Ypsomed Price Target

Target Price CHF426.00
Price CHF364.00
Potential
Number of Estimates 6
6 Analysts have issued a price target Ypsomed 2025 . The average Ypsomed target price is CHF426.00. This is higher than the current stock price. The highest price target is
CHF495.00 35.99%
register free of charge
, the lowest is
CHF326.00 10.44%
register free of charge
.
A rating was issued by 7 analysts: 3 Analysts recommend Ypsomed to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ypsomed stock has an average upside potential 2025 of . Most analysts recommend the Ypsomed stock at Buy or hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates
Revenue Million CHF 548.46 674.12
10.25% 22.91%
EBITDA Margin 28.43% 30.39%
22.07% 6.89%
Net Margin 14.26% 16.93%
36.29% 18.68%

5 Analysts have issued a sales forecast Ypsomed 2025 . The average Ypsomed sales estimate is

CHF674m
Unlock
. This is
9.24% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF687m 11.33%
Unlock
, the lowest is
CHF660m 6.96%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CHF548m 10.25%
2025
CHF674m 22.91%
Unlock
2026
CHF809m 20.00%
Unlock
2027
CHF969m 19.84%
Unlock
2028
CHF1.1b 15.22%
Unlock
2029
CHF1.3b 15.76%
Unlock

5 Analysts have issued an Ypsomed EBITDA forecast 2025. The average Ypsomed EBITDA estimate is

CHF205m
Unlock
. This is
14.61% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF229m 28.10%
Unlock
, the lowest is
CHF166m 7.14%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CHF156m 34.58%
2025
CHF205m 31.39%
Unlock
2026
CHF297m 45.10%
Unlock
2027
CHF365m 22.76%
Unlock
2028
CHF498m 36.46%
Unlock
2029
CHF575m 15.46%
Unlock

EBITDA Margin

2024 28.43% 22.07%
2025
30.39% 6.89%
Unlock
2026
36.75% 20.93%
Unlock
2027
37.64% 2.42%
Unlock
2028
44.58% 18.44%
Unlock
2029
44.47% 0.25%
Unlock

3 Ypsomed Analysts have issued a net profit forecast 2025. The average Ypsomed net profit estimate is

CHF114m
Unlock
. This is
53.65% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF124m 66.42%
Unlock
, the lowest is
CHF101m 36.18%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CHF78.2m 50.26%
2025
CHF114m 45.89%
Unlock
2026
CHF170m 48.64%
Unlock
2027
CHF208m 22.62%
Unlock
2028
CHF282m 35.52%
Unlock

Net Margin

2024 14.26% 36.29%
2025
16.93% 18.68%
Unlock
2026
20.97% 23.86%
Unlock
2027
21.46% 2.34%
Unlock
2028
25.24% 17.61%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates
Earnings Per Share CHF 5.74 8.37
50.26% 45.82%
P/E 43.47
EV/Sales 7.77

3 Analysts have issued a Ypsomed forecast for earnings per share. The average Ypsomed <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

CHF8.37
Unlock
. This is
53.58% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
CHF9.07 66.42%
Unlock
, the lowest is
CHF7.42 36.15%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CHF5.74 50.26%
2025
CHF8.37 45.82%
Unlock
2026
CHF12.45 48.75%
Unlock
2027
CHF15.26 22.57%
Unlock
2028
CHF20.68 35.52%
Unlock

P/E ratio

Current 66.74 2.53%
2025
43.47 34.87%
Unlock
2026
29.24 32.74%
Unlock
2027
23.85 18.43%
Unlock
2028
17.60 26.21%
Unlock

Based on analysts' sales estimates for 2025, the Ypsomed stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.48 14.75%
2025
7.77 8.42%
Unlock
2026
6.47 16.67%
Unlock
2027
5.40 16.56%
Unlock
2028
4.69 13.21%
Unlock
2029
4.05 13.61%
Unlock

P/S ratio

Current 8.04 12.88%
2025
7.36 8.46%
Unlock
2026
6.13 16.67%
Unlock
2027
5.12 16.56%
Unlock
2028
4.44 13.21%
Unlock
2029
3.84 13.61%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today